Skip to content

Clinical investigation of Helicobacter pylori infection and eradication therapy.

Clinical investigation of Helicobacter pylori infection and eradication therapy. - Clinical investigation of Helicobacter pylori infection and eradication therapy.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000012036
Enrollment
5000
Registered
2013-10-15
Start date
2013-08-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who undergo EGD.

Interventions

None listed

Sponsors

Tokyo medical
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients undergoing upper GI endoscopy at the Chofu-Touzan hospital

Exclusion criteria

Exclusion criteria: patients without agreement

Design outcomes

Primary

MeasureTime frame
To investigate the past history of H. pylori eradication and the severity of endoscopic gastric atrophy.

Secondary

MeasureTime frame
To investigate the evaluation methods of H. pylori infection and the reason. To investigate the correlation between frequency of evaluation of H. pylori infection and medication about anticoagulants.

Countries

Japan

Contacts

Public ContactShin Kono

Tokyo Medical University Gastroenterology and Hepatology

shin_kono0527@yahoo.co.jp09041598591

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026